Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;2(4):227-9.
doi: 10.1007/s12348-012-0080-z. Epub 2012 May 16.

Adalimumab for refractory peripheral ulcerative keratitis

Miguel Cordero-Coma  1 , Raquel Salazar Méndez, Alvaro Casado Blanco, Ana López Corral, Sara Calleja-Antolín, José M Ruiz de Morales
Affiliations

Adalimumab for refractory peripheral ulcerative keratitis

Miguel Cordero-Coma et al. J Ophthalmic Inflamm Infect. 2012 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Slit lamp examination of patient 2 after the second tectonic penetrating keratoplasty. Observe the relapse of the peripheral ulcerative keratitis with corneal ulceration located at the same place of initial onset
Fig. 2
Fig. 2
Slit lamp examination of patient 2 12 months after the initiation of therapy with adalimumab. Observe a complete resolution of the underlying inflammation and a residual corneal thinning
See this image and copyright information in PMC

References

    1. Foster CS. Mooren’s ulcer. In: Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft’s: The cornea, scientific foundations and clinical practice. 4. Philadelphia: Williams & Wilkins; 2005. pp. 551–557.
    1. Reinisch W, Sandborn WJ, Hommes DW, D'Haens G, Hanauer S, Schreiber S, Panaccione R, Fedorak RN, Tighe MB, Huang B, Kampman W, Lazar A, Thakkar R. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. Gut. 2011;60(6):780–787. doi: 10.1136/gut.2010.221127. - DOI - PubMed
    1. Wiens A, Venson R, Correr CJ, Otuki MF, Pontarolo R. Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis. Pharmacotherapy. 2010;30(4):339–353. doi: 10.1592/phco.30.4.339. - DOI - PubMed
    1. Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U. Tumour necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol. 2003;87:548–550. doi: 10.1136/bjo.87.5.548. - DOI - PMC - PubMed
    1. Cordero-Coma M, Benito MF, Fuertes CL, Antolín SC, García Ruíz JM. Adalimumab for Mooren's ulcer. Ophthalmology. 2009;116:1589. doi: 10.1016/j.ophtha.2009.03.019. - DOI - PubMed

LinkOut - more resources